{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "2395",
  "company_name": "新日本科学",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/2395/current/#revenue-mix",
  "api_url": "/api/2395/financials/segment.json",
  "updated": "2026-09-19",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/2395/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    }
  },
  "html_url": "https://the-shashi.com/tse/2395/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 9.46,
      "profit": -426.33,
      "assets": 3.92
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 815.22,
      "profit": 58.47,
      "assets": 1659.49
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "前臨床事業",
      "sales": 11791.43,
      "profit": -3313.45,
      "assets": 24670.41
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床事業",
      "sales": 2126.65,
      "profit": -224.49,
      "assets": 3957.98
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 24.17,
      "profit": -250.78,
      "assets": 5.84
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 662.02,
      "profit": -158.96,
      "assets": 1594.57
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "前臨床事業",
      "sales": 12905.17,
      "profit": -1714.62,
      "assets": 23437.67
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床事業",
      "sales": 3649.07,
      "profit": 276.43,
      "assets": 1941.81
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 39.69,
      "profit": -245.82,
      "assets": 0.08
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 912.46,
      "profit": 12.18,
      "assets": 1624.73
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "前臨床事業",
      "sales": 13904.88,
      "profit": -623.5,
      "assets": 20901.07
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床事業",
      "sales": 1741.53,
      "profit": 127.42,
      "assets": 1396.02
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 11.54,
      "profit": -299.31,
      "assets": 5.46
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 931.27,
      "profit": -239.34,
      "assets": 1546.96
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "前臨床事業",
      "sales": 13717.25,
      "profit": 1386.05,
      "assets": 17055.15
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床事業",
      "sales": 981.29,
      "profit": 56.89,
      "assets": 850.24
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "CRO事業",
      "sales": 13473.5,
      "profit": 2879.95,
      "assets": 16563.01
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 0.21,
      "profit": -613.41,
      "assets": 18.33
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 931.36,
      "profit": -0.59,
      "assets": 2251.86
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "CRO事業",
      "sales": 14435.28,
      "profit": 3393.22,
      "assets": 16574.06
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 12.24,
      "profit": -708.03,
      "assets": 96.85
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 512.94,
      "profit": -54.9,
      "assets": 1274.72
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "CRO事業",
      "sales": 16943.91,
      "profit": 5035.69,
      "assets": 17811.01
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 12.06,
      "profit": -746.99,
      "assets": 90.04
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 528.03,
      "profit": -17.8,
      "assets": 1848.94
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "CRO事業",
      "sales": 23924.37,
      "profit": 6336.63,
      "assets": 28277.14
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 16.48,
      "profit": -879.98,
      "assets": 102.62
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 600.83,
      "profit": -203.98,
      "assets": 1980.79
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "CRO事業",
      "sales": 25660.79,
      "profit": 7023.31,
      "assets": 38751.68
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 11.67,
      "profit": -2469.6,
      "assets": 1942.44
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 477.55,
      "profit": -254.43,
      "assets": 2161.81
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "CRO事業",
      "sales": 31514.52,
      "profit": 7257.73,
      "assets": 43916.45
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "トランスレーショナルリサーチ事業",
      "sales": 54.16,
      "profit": -3680.52,
      "assets": 3114.27
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "メディポリス事業",
      "sales": 470.4,
      "profit": -422.32,
      "assets": 2087.36
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米国不動産事業",
      "sales": 45.98,
      "profit": -60.5,
      "assets": 6223.89
    }
  ],
  "region": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 10687593
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "北米",
      "sales": 3172206
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 890272
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 10832700
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "北米",
      "sales": 5714137
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 697658
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 11732159
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 4024964
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 843427
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 11643901
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 3367981
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 646794
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 12243939
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 1248027
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 1069117
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 13010106
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 1644789
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 455651
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 14657120
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 1933591
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 1157771
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 18515031
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 3843168
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 2732703
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 17811980
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 4481908
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "韓国",
      "sales": 3763365
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 393214
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 21524370
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アメリカ合衆国",
      "sales": 6372363
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "韓国",
      "sales": 4018865
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "千円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 498206
    }
  ]
}